The Iliac/SFA/Popliteal Center

Filter Your Results

 

News

 

Regulation of Peripheral Vascular Devices

David S. Buckles; Jennifer L. Goode; and Dorothy B. Abel

August 2005—Current issues in the regulation of SFA stents.

Therapeutic Angiogenesis

Toshio Matsuhashi, MD; Dara L. Kraitchman, VMD, PhD; and Lawrence V. Hofmann, MD

July 2005—Is peripheral arterial disease treatment evolving from stents to stem cells?

The Unconquered Ordeal

Takao Ohki, MD, PhD, Chief Medical Editor, Endovascular Today

June 2005—Why does this vessel continue to elude long-term success, and which technique, if any, will ultimately solve this problem?

Remote SFA Disease: Facing Reality

Takao Ohki, MD, PhD, Chief Medical Editor, Endovascular Today

June 2005—Why does this vessel continue to elude long-term success, and which technique, if any, will ultimately solve this problem?

SFA Angioplasty Versus Femoropopliteal Bypass

Heather Y. Wolford, MD; Scott M. Surowiec, MD; and Mark G. Davies, MD, PhD

June 2005—What can we realistically expect?

Long Nitinol Stenting in the Femoropopliteal System

Frank J. Arena, MD, FACC, FSCAI

June 2005—Unintended consequences of nitinol stenting on endovascular treatment of the superficial femoral and popliteal arteries.

Biomechanical Forces in the Femoropopliteal Arterial Segment

H. Bob Smouse, MD; Alexander Nikanorov, MD, PhD; and Danielle LaFlash

June 2005—What happens during extremity movement and what is the effect on stenting?

Plaque Excision Treatment of Infrainguinal PAD

Roger Gammon, MD

June 2005—An update on this nonstenting alternative, with intermediate-term results of the ongoing TALON Registry.

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.